Common pathogenic mechanisms and pathways in the development of COPD and lung cancer

Author： Yang Ian A   Relan Vandana   Wright Casey M   Davidson Morgan R   Sriram Krishna B   Savarimuthu Francis Santiyagu M   Clarke Belinda E   Duhig Edwina E   Bowman Rayleen V   Fong Kwun M  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.15, Iss.4, 2011-04, pp. : 439-456

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Signaling Pathways Modulating Dependence of Lung Cancer on Mutant Epidermal Growth Factor Receptor and Mechanisms of Intrinsic and Acquired Resistance to Tyrosine Kinase Inhibitors

By  

Current Pharmaceutical Design, Vol. 20, Iss. 24, 2014-05 ,pp. : 3883-3893

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Mechanisms and Modulation of Key Pathways Underlying the Synergistic Interaction of Sorafenib with Erlotinib in Non-Small-Cell-Lung Cancer (NSCLC) Cells

By  

Current Pharmaceutical Design, Vol. 19, Iss. 5, 2013-02 ,pp. : 927-939

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting signaling pathways in lung cancer therapy

By Cho William CS  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 2, 2013-02 ,pp. : 107-111

Informa Healthcare

Access to resources Recommend Favorite

Targeting Apoptotic Signaling Pathways in Human Lung Cancer

By  

Current Cancer Drug Targets, Vol. 10, Iss. 6, 2010-09 ,pp. : 566-574

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the anaphase promoting complex: common pathways for viral infection and cancer therapy

By Smolders Linda   Teodoro Jose G  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 6, 2011-06 ,pp. : 767-780

Informa Healthcare

Access to resources Recommend Favorite